Research progress in the molecular mechanisms, therapeutic targets, and drug development of idiopathic pulmonary fibrosis

H Ma, X Wu, Y Li, Y Xia - Frontiers in Pharmacology, 2022 - frontiersin.org
Idiopathic pulmonary fibrosis (IPF) is a fatal interstitial lung disease. Recent studies have
identified the key role of crosstalk between dysregulated epithelial cells, mesenchymal …

Thoracic manifestations of rheumatoid arthritis

AJ Esposito, SG Chu, R Madan… - Clinics in chest …, 2019 - chestmed.theclinics.com
Rheumatoid arthritis (RA) is a destructive, systemic, inflammatory disorder that
characteristically affects small, diarthrodial joints in a progressive, symmetric, and erosive …

Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases

SN Lin, R Mao, C Qian, D Bettenworth… - Physiological …, 2022 - journals.physiology.org
Intestinal fibrosis is considered an inevitable complication of Crohn's disease (CD) that
results in symptoms of obstruction and stricture formation. Endoscopic or surgical treatment …

Review of the recombinant human interferon gamma as an immunotherapeutic: Impacts of production platforms and glycosylation

A Razaghi, L Owens, K Heimann - Journal of biotechnology, 2016 - Elsevier
Human interferon gamma is a cytokine belonging to a diverse group of interferons which
have a crucial immunological function against mycobacteria and a wide variety of viral …

Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis

H Loomis-King, KR Flaherty, BB Moore - Current opinion in pharmacology, 2013 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease (ILD) of unknown
origin characterized by epithelial cell dysfunctions, accumulation of fibroblasts and …

Interferon gamma peptidomimetic targeted to hepatic stellate cells ameliorates acute and chronic liver fibrosis in vivo

R Bansal, J Prakash, M De Ruiter, K Poelstra - Journal of controlled release, 2014 - Elsevier
Hepatic stellate cells play a crucial role in the pathogenesis of hepatic fibrosis. Thus,
pharmacological inhibition of pro-fibrotic activities of these cells might lead to an effective …

The chemokine, CCL3, and its receptor, CCR1, mediate thoracic radiation–induced pulmonary fibrosis

X Yang, W Walton, DN Cook, X Hua… - American journal of …, 2011 - atsjournals.org
Patients receiving thoracic radiation often develop pulmonary injury and fibrosis. Currently,
there are no effective measures to prevent or treat these conditions. We tested whether …

Biologic treatments in interstitial lung diseases

T Karampitsakos, A Vraka, D Bouros, SN Liossis… - Frontiers in …, 2019 - frontiersin.org
Interstitial lung diseases (ILD) represent a group of heterogeneous parenchymal lung
disorders with complex pathophysiology, characterized by different clinical and radiological …

PEGylation improves pharmacokinetic profile, liver uptake and efficacy of Interferon gamma in liver fibrosis

R Bansal, E Post, JH Proost, A de Jager-Krikken… - Journal of controlled …, 2011 - Elsevier
Interferon gamma (IFNγ) is a potent cytokine that displays a variety of anti-viral, anti-
proliferative, immunomodulatory, apoptotic and anti-fibrotic functions. However, its clinical …

Type I IFNs regulate inflammation, vasculopathy, and fibrosis in chronic cutaneous graft-versus-host disease

TA Delaney, C Morehouse, PZ Brohawn… - The Journal of …, 2016 - journals.aai.org
Type I IFNs play a critical role in the immune response to viral infection and may also drive
autoimmunity through modulation of monocyte maturation and promotion of autoreactive …